SCHEMBL2002523

SCHEMBL2002523

O=c1c2ccccc2[nH]c2oc3ccccc3c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.52
▸ ALDH1A1 P00352 3/20 0.52
▸ GLA P06280 3/20 0.52
▸ GAA P10253 3/20 0.52
▸ HPGD P15428 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ HTT P42858 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ MAOA P21397 3/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ PGAM1 P18669 1/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ F2 P00734 1/20 0.44
▸ CFD P00746 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31606608 0.85 ALDH1A1 (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL15024931 0.85 ALDH1A1 (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL10614221 0.84 MAOA (0.54) GAAMAOATDP1KDM5ACDK5
SCHEMBL589935 0.76 KDM4E (0.52) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL8691721 0.74 ERCC5 (0.54) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL18018247 0.74 HCAR2 (0.45) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL29755033 0.73 KDM5A (0.51) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL11768528 0.73 KDM5A (0.51) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL9768431 0.72 MAP3K11 (0.49) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL12849391 0.72 MAOA (0.52) KDM4EALDH1A1GLAGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960548-B2 Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-06-14 — — US disclosed
US-7960548-B2 Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-06-14 — — US disclosed
US-20070078176-A1 Keratinocyte growth factor receptor-tyrosine specific inhibitors for the prevention of cancer metastatis US ARMY, SECRETARY OF THE ARMY 2007-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078176-A1 Keratinocyte growth factor receptor-tyrosine specific inhibitors for the prevention of cancer metastatis FGFR1, FGFR3, MET KDM4E 2093/4885ALDH1A1 1697/4885GLA 704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback